tiprankstipranks
Exagen Inc (XGN)
NASDAQ:XGN
US Market

Exagen (XGN) Income Statement

Compare
146 Followers

Exagen Income Statement

Last quarter (Q3 2024), Exagen's total revenue was $12.51M, a decrease of -6.78% from the same quarter last year. In Q3, Exagen's net income was $-5.03M. See Exagen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 52.55M$ 45.56M$ 48.30M$ 41.98M$ 40.39M
Gross Profit
$ 29.46M$ 21.35M$ 27.71M$ 25.42M$ 21.58M
Operating Expenses
$ 52.29M$ 61.89M$ 51.78M$ 40.60M$ 30.88M
Depreciation and Amortization
$ 2.17M$ 2.11M$ 948.00K$ 546.00K$ 591.00K
EBITDA
$ -19.15M$ -43.11M$ -23.10M$ -13.65M$ -7.93M
Operating Income
$ -22.84M$ -40.55M$ -24.07M$ -15.19M$ -9.30M
Other Income/Expenses
$ -819.00K$ -1.62M$ -2.61M$ -1.58M$ -2.71M
Pretax Income
$ -23.66M$ -47.67M$ -26.68M$ -16.77M$ -12.01M
Net Income
$ -23.69M$ -47.39M$ -26.85M$ -16.69M$ -12.04M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.34$ -2.77$ -1.68$ -1.32$ -0.96
Diluted EPS
$ -1.34$ -2.77$ -1.68$ -1.32$ -0.96
Weighted Average Shares Outstanding
17.68M 17.08M 15.97M 12.65M 12.56M
Weighted Average Shares Outstanding (Diluted)
17.68M 17.08M 15.97M 12.65M 12.56M
Currency in USD

Exagen Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis